Thrombin Market Industry Analysis, Potential Growth by 2025 Thrombin Markets | Page 4

Thrombin Market Size, Share and Global Trend by Product (Bovine Thrombin, Human
Thrombin, Recombinant Thrombin), By Dosage Form (Powder Form, Solution Form), By End-
user (Hospitals, Diagnostics Centres & Clinics, Academics and Research Institutes), and
Geography Forecast till 2026
As of now, Recothrom is the only drug that has been clinically approved for commercial use as a
recombinant thrombin brand. Furthermore, Recothrom finds applications in cases where standard
surgical procedures such as suture or cautery are ineffective.
Top Players Mentioned:
Besides Baxter, there have been significant activities from other companies that have contributed to
the growth of the global thrombin market. Attractive business strategies of companies such as Pfizer
have had a positive impact on the overall market.
•
•
•
•
•
•
Pfizer Inc.
Johnson & Johnson Services Inc.
Baxter
Shanghai RAAS blood products co. Ltd.
Japan Blood Products Organization
Mochida Pharmaceutical Co.
Speak to Analyst:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dental-implants-market-
Fortune Business Insights Pvt Ltd.
100443